HUGE

FSD Pharma Inc. (HUGE) | Rumor.io

FSD Pharma

HUGE

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about HUGE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Apr 1

FSD Pharma Inc. (HUGE) is involved in an exchange of lawsuits with Safety Shot (SHOT), despite SHOT's 61% increase in the last 6 months.
Safety Shot claims to be able to cut blood alcohol in half within an hour, which could be a key development in the alcohol detox market.
The alcohol detox market is potentially significant, with an average of 2.5 thousand people dying from alcohol poisoning in the US annually between 2017 and 2020.

Generated by AI

Sentiment

Of the messages about HUGE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	16.13% -79.87
Bearish	—	—	—	83.87% +79.87

Bullish· Mar 17

$HUGE has seen significant price appreciation, with a 38.41% gain in pre-market trading.
The company's recent licensing agreement for veterinary drugs in dogs and cats has led to a surge in share value, making it a promising investment opportunity.
$HUGE has shown strong volume and price action, with 8.5 million shares traded in pre-market, and is expected to be a strong earnings winner.

Bearish· Mar 17

The shorts in $HUGE have been successful in preventing the stock from rising, with a significant spike in volume not translating to higher prices.
The company's float has increased consistently over time, with the most recent offering adding around 7.3M shares to the float, which may put downward pressure on the stock.
The stock has struggled to hold gains, with a notable example being a failed attempt to hold above the VWAP on the 1M chart, suggesting a lack of momentum and conviction in the stock's upward movement.

Generated by AI

Topics

Of the messages about HUGE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0%
Announcements	100%	100%	100%	100%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0%

Apr 12

FSD Pharma Inc. (HUGE) plans to spin out a subsidiary as a distribution to shareholders, with a shareholder meeting scheduled for June 29, 2023.
The spin-out is expected to be completed in July 2023, with shareholders voting on May 15, and potentially equating to 1 free share of the spinoff company for each share of HUGE held.
The spin-out will make the subsidiary a "reporting issuer" in the same jurisdictions in Canada where FSD Pharma is currently a reporting issuer.

Generated by AI

Community

Of the messages about HUGE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0%
Newcomers	—	—	100%	100%

Regulars· Jan 13

FSD Pharma Inc. has announced a share repurchase program, authorizing the repurchase of up to 1.93 million of its subordinate class B voting shares over the next 12 months.
The share repurchase program has been well-received by the market, with FSD Pharma stock rising 12.4% pre-market and continuing to advance in an uptrend.
The company plans to utilize cash reserves to fund the share buyback, with the goal of taking advantage of current market conditions to increase shareholder value.

Newcomers· Nov 21

The newcomer is considering $HUGE as a potential "next SHOT" due to its strong performance in a tough market, despite some concerns about lawsuits and spinoff complications.
The newcomer has started a position in $HUGE for a swing trade, citing the popularity of the company's "detoxification" drinks and its well-known distribution team, including Kevin Harrington and Gerry David.
The newcomer is attracted to $HUGE's spinoff of its drink business, Unbuzzd, which has received shareholder approval and is expected to be spun off soon, with a 1:1 ratio for FSD Pharma shareholders.

Generated by AI

Also Discussed

Investors talking about HUGE also mention

#	Name	Attention
1	GBNH - Greenbrook TMS Inc.	——
2	Safety Shot Inc.SHOT	0%0
3	Imperial Oil LimitedIMO	0%0
4	AAU - Almaden Minerals Ltd.	——
5	CEO - CNOOC Limited	——
6	BIG - Big Lots, Inc.	——
7	Organigram Global Inc.OGI	0%0
8	GoldMining Inc.GLDG	0%new
9	PharmaCyte Biotech, Inc.PMCB	0%0
10	Gladstone Commercial CorporationGOOD	0%0

FSD Pharma Inc.

Location

Social

What share of all stock conversation is about HUGE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Apr 1

FSD Pharma Inc. (HUGE) is involved in an exchange of lawsuits with Safety Shot (SHOT), despite SHOT's 61% increase in the last 6 months.
Safety Shot claims to be able to cut blood alcohol in half within an hour, which could be a key development in the alcohol detox market.
The alcohol detox market is potentially significant, with an average of 2.5 thousand people dying from alcohol poisoning in the US annually between 2017 and 2020.

Generated by AI

Sentiment

Of the messages about HUGE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	16.13% -79.87
Bearish	—	—	—	83.87% +79.87

Bullish· Mar 17

$HUGE has seen significant price appreciation, with a 38.41% gain in pre-market trading.
The company's recent licensing agreement for veterinary drugs in dogs and cats has led to a surge in share value, making it a promising investment opportunity.
$HUGE has shown strong volume and price action, with 8.5 million shares traded in pre-market, and is expected to be a strong earnings winner.

Bearish· Mar 17

The shorts in $HUGE have been successful in preventing the stock from rising, with a significant spike in volume not translating to higher prices.
The company's float has increased consistently over time, with the most recent offering adding around 7.3M shares to the float, which may put downward pressure on the stock.
The stock has struggled to hold gains, with a notable example being a failed attempt to hold above the VWAP on the 1M chart, suggesting a lack of momentum and conviction in the stock's upward movement.

Generated by AI

Topics

Of the messages about HUGE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0%
Announcements	100%	100%	100%	100%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	0%

Apr 12

FSD Pharma Inc. (HUGE) plans to spin out a subsidiary as a distribution to shareholders, with a shareholder meeting scheduled for June 29, 2023.
The spin-out is expected to be completed in July 2023, with shareholders voting on May 15, and potentially equating to 1 free share of the spinoff company for each share of HUGE held.
The spin-out will make the subsidiary a "reporting issuer" in the same jurisdictions in Canada where FSD Pharma is currently a reporting issuer.

Generated by AI

Community

Of the messages about HUGE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0%
Newcomers	—	—	100%	100%

Regulars· Jan 13

FSD Pharma Inc. has announced a share repurchase program, authorizing the repurchase of up to 1.93 million of its subordinate class B voting shares over the next 12 months.
The share repurchase program has been well-received by the market, with FSD Pharma stock rising 12.4% pre-market and continuing to advance in an uptrend.
The company plans to utilize cash reserves to fund the share buyback, with the goal of taking advantage of current market conditions to increase shareholder value.

Newcomers· Nov 21

The newcomer is considering $HUGE as a potential "next SHOT" due to its strong performance in a tough market, despite some concerns about lawsuits and spinoff complications.
The newcomer has started a position in $HUGE for a swing trade, citing the popularity of the company's "detoxification" drinks and its well-known distribution team, including Kevin Harrington and Gerry David.
The newcomer is attracted to $HUGE's spinoff of its drink business, Unbuzzd, which has received shareholder approval and is expected to be spun off soon, with a 1:1 ratio for FSD Pharma shareholders.

Generated by AI

FSD Pharma

Social

Apr 1

Sentiment

Bullish· Mar 17

Bearish· Mar 17

Topics

Apr 12

Community

Regulars· Jan 13

Newcomers· Nov 21

Also Discussed

FSD Pharma Inc.

Company Information

Location

Also Discussed

Social

Apr 1

Sentiment

Bullish· Mar 17

Bearish· Mar 17

Topics

Apr 12

Community

Regulars· Jan 13

Newcomers· Nov 21